Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Multifaceted Approach Cuts Unnecessary Inpatient Lab Testing, Reduces Costs
...
Already a member? Log in here
Annual Self-Screening With FIT Effective for Colorectal Cancer Detection
...
Already a member? Log in here
Inflammatory Markers May Diagnose Back Conditions
...
Already a member? Log in here
NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis
...
Already a member? Log in here
Acute HIV Screening With Combo Assay Ups Diagnostic Yield
...
Already a member? Log in here
Ambry Genetics Launches Public Genetic Database, Takes Stand on Data Sharing
From - Diagnostic Testing & Emerging Technologies
Ambry Genetics (Aliso Viejo, Calif.) took a stance in the debate over sharing of genetic data this week. The genetic testing firm launched…
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
